Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionChildhood Chronic Myelogenous LeukemiaChildhood Myelodysplastic SyndromesChronic Phase Chronic Myelogenous Leukemiade Novo Myelodysplastic SyndromesDisseminated NeuroblastomaJuvenile Myelomonocytic LeukemiaPreviously Treated Childhood RhabdomyosarcomaPreviously Treated Myelodysplastic SyndromesPulmonary ComplicationsRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Large Cell LymphomaRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood RhabdomyosarcomaRecurrent Childhood Small Noncleaved Cell LymphomaRecurrent NeuroblastomaRecurrent Wilms Tumor and Other Childhood Kidney TumorsRecurrent/Refractory Childhood Hodgkin LymphomaRelapsing Chronic Myelogenous LeukemiaSecondary Acute Myeloid LeukemiaSecondary Myelodysplastic Syndromes
Interventions
BIOLOGICAL

etanercept

Given IV and subcutaneously

DRUG

methylprednisolone

Given IV and orally

Trial Locations (26)

10032

Columbia University Medical Center, New York

10595

New York Medical College, Valhalla

15224

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

29425

Medical University of South Carolina, Charleston

30322

Children's Healthcare of Atlanta - Egleston, Atlanta

33701

All Children's Hospital, St. Petersburg

35294

University of Alabama at Birmingham, Birmingham

46202

Indiana University Cancer Center, Indianapolis

Indiana University Medical Center, Indianapolis

48109

C S Mott Children's Hospital, Ann Arbor

53226

Midwest Children's Cancer Center, Milwaukee

60614

Childrens Memorial Hospital, Chicago

68198

University of Nebraska Medical Center, Omaha

70118

Children's Hospital-Main Campus, New Orleans

75390

University of Texas Southwestern Medical Center, Dallas

76104

Cook Children's Medical Center, Fort Worth

78229

Methodist Children's Hospital of South Texas, San Antonio

80045

Children's Hospital Colorado, Aurora

92354

Loma Linda University Medical Center, Loma Linda

97239

Oregon Health and Science University, Portland

98105

Seattle Children's Hospital, Seattle

91006-3776

Children's Oncology Group, Arcadia

21287-8936

Johns Hopkins University, Baltimore

07601

Hackensack University Medical Center, Hackensack

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00309907 - Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter